Sean C. Dowdy, MD | Authors


Bevacizumab and Improvement of PFS in Ovarian Cancer

June 13, 2014

Sean C. Dowdy, MD, professor, chair, Division of Gynecologic Surgery, co-leader, Women’s Cancer Program, Mayo Clinic, discusses bevacizumab and improvement of progression-free survival (PFS) for patients with the mesenchymal molecular subtype of ovarian cancer.